0000899243-17-018635.txt : 20170720
0000899243-17-018635.hdr.sgml : 20170720
20170720163612
ACCESSION NUMBER: 0000899243-17-018635
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170718
FILED AS OF DATE: 20170720
DATE AS OF CHANGE: 20170720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pomerantz Roger
CENTRAL INDEX KEY: 0001614936
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37465
FILM NUMBER: 17974659
MAIL ADDRESS:
STREET 1: 711 HARVEST HILL ROAD
CITY: CHALFONT
STATE: PA
ZIP: 18914
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seres Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274326290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 945 9626
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Seres Health, Inc.
DATE OF NAME CHANGE: 20140603
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-18
0
0001609809
Seres Therapeutics, Inc.
MCRB
0001614936
Pomerantz Roger
C/O SERES THERAPEUTICS, INC.
200 SIDNEY STREET
CAMBRIDGE
MA
02139
1
1
0
0
President and CEO
Common Stock
2017-07-18
4
M
0
100604
0.71
A
284296
D
Stock Option (right to buy)
0.71
2017-07-18
4
M
0
100604
0.00
D
2024-08-07
Common Stock
100604
951682
D
The option vested as to 25% of the shares on June 1, 2015. The remainder of the shares have vested or will vest in 12 equal quarterly installments thereafter.
/s/ Thomas J. DesRosier, Attorney-in-Fact
2017-07-20